ask="N/A"
ask_size="N/A"
average_daily_volume="53155"
bid="12.150"
bid_size="100"
book_value="3.146"
change="-0.225"
change_from_200_day_moving_average="2.501"
change_from_50_day_moving_average="0.525"
change_from_52_week_high="-0.785"
change_From_52_week_low="9.085"
change_in_percent="-1.060%"
close="21.005"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.718"
ebitda="-68.26M"
eps_estimate_current_year="-2.360"
eps_estimate_next_quarter="-0.580"
eps_estimate_next_year="-2.090"
ex_dividend_date="N/A"
float_shares="10188000"
high="21.369"
high_52_weeks="21.790"
last_trade_date="1/23/2017"
last_trade_price="21.005"
last_trade_size="100"
last_trade_time="4:00pm"
low="20.710"
low_52_weeks="11.920"
market_capitalization="529.52M"
moving_average_200_day="18.504"
moving_average_50_day="20.480"
name="Ascendis Pharma A/S"
notes="N/A"
one_year_target_price="29.670"
open="21.050"
pe_ratio="N/A"
peg_ratio="-0.370"
percent_change_from_200_day_moving_average="+13.518%"
percent_change_from_50_day_moving_average="+2.563%"
percent_change_from_52_week_high="-3.603%"
percent_change_from_52_week_low="+76.216%"
previous_close="21.230"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.748"
price_per_sales="90.633"
revenue="5.90M"
shares_outstanding="25209000"
short_ratio="8.240"
stock_exchange="NMS"
symbol="ASND"
volume="33568"
weeks_range_52="11.920 - 21.790"
